Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel analgesic agents disclosed in recent patent literature

Feb. 25, 2008

Proteomic analysis identifies new potential targets for multiple sclerosis

Feb. 22, 2008

New compounds for treating pain and other inflammatory conditions described in recent patents

Feb. 22, 2008

NeuroHealing initiates phase II clinical trial of NH-004 for sialorrhea in PD patients

Feb. 22, 2008

Memory and Roche to initiate biomarker clinical study of MEM-3454 for schizophrenia

Feb. 20, 2008

Cognitive improvement seen with intranasal insulin in early Alzheimer's disease

Feb. 20, 2008

Newron completes enrollment in phase II study of ralfinamide in post-op dental pain

Feb. 19, 2008

Lundbeck initiates enrollment in phase II clinical study of Lu-AA-34893 for bipolar disorder

Feb. 19, 2008

LAT-967 shows potential for AD by inducing Sp1 degradation

Feb. 19, 2008

FDA grants fast track status to levodopa/carbidopa intestinal gel

Feb. 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...